![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: AMBRA1 |
Gene summary for AMBRA1 |
![]() |
Gene information | Species | Human | Gene symbol | AMBRA1 | Gene ID | 55626 |
Gene name | autophagy and beclin 1 regulator 1 | |
Gene Alias | DCAF3 | |
Cytomap | 11p11.2 | |
Gene Type | protein-coding | GO ID | GO:0000045 | UniProtAcc | Q9C0C7 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
55626 | AMBRA1 | CCI_1 | Human | Cervix | CC | 6.89e-10 | 6.65e-01 | 0.528 |
55626 | AMBRA1 | CCI_2 | Human | Cervix | CC | 2.16e-22 | 1.39e+00 | 0.5249 |
55626 | AMBRA1 | CCI_3 | Human | Cervix | CC | 9.69e-18 | 9.62e-01 | 0.516 |
55626 | AMBRA1 | HTA11_3410_2000001011 | Human | Colorectum | AD | 2.21e-15 | -5.85e-01 | 0.0155 |
55626 | AMBRA1 | HTA11_7862_2000001011 | Human | Colorectum | AD | 1.09e-02 | -4.36e-01 | -0.0179 |
55626 | AMBRA1 | HTA11_866_3004761011 | Human | Colorectum | AD | 1.61e-04 | -3.60e-01 | 0.096 |
55626 | AMBRA1 | HTA11_10711_2000001011 | Human | Colorectum | AD | 7.80e-03 | -4.04e-01 | 0.0338 |
55626 | AMBRA1 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 3.77e-11 | -4.94e-01 | 0.294 |
55626 | AMBRA1 | HTA11_99999965104_69814 | Human | Colorectum | MSS | 1.91e-18 | 1.01e+00 | 0.281 |
55626 | AMBRA1 | HTA11_99999974143_84620 | Human | Colorectum | MSS | 6.41e-13 | -4.86e-01 | 0.3005 |
55626 | AMBRA1 | F007 | Human | Colorectum | FAP | 1.21e-02 | -3.65e-01 | 0.1176 |
55626 | AMBRA1 | A015-C-203 | Human | Colorectum | FAP | 9.92e-35 | -3.50e-01 | -0.1294 |
55626 | AMBRA1 | A015-C-204 | Human | Colorectum | FAP | 5.10e-05 | -3.42e-01 | -0.0228 |
55626 | AMBRA1 | A014-C-040 | Human | Colorectum | FAP | 8.90e-04 | -3.71e-01 | -0.1184 |
55626 | AMBRA1 | A002-C-201 | Human | Colorectum | FAP | 1.05e-12 | -3.63e-01 | 0.0324 |
55626 | AMBRA1 | A002-C-203 | Human | Colorectum | FAP | 9.46e-05 | -3.02e-02 | 0.2786 |
55626 | AMBRA1 | A001-C-119 | Human | Colorectum | FAP | 1.73e-07 | 8.26e-02 | -0.1557 |
55626 | AMBRA1 | A001-C-108 | Human | Colorectum | FAP | 2.59e-18 | -1.87e-01 | -0.0272 |
55626 | AMBRA1 | A002-C-205 | Human | Colorectum | FAP | 2.17e-22 | -3.00e-01 | -0.1236 |
55626 | AMBRA1 | A001-C-104 | Human | Colorectum | FAP | 3.36e-08 | -2.23e-01 | 0.0184 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000703312 | Prostate | Tumor | vacuole organization | 47/3246 | 180/18723 | 1.95e-03 | 1.13e-02 | 47 |
GO:00192166 | Prostate | Tumor | regulation of lipid metabolic process | 76/3246 | 331/18723 | 5.04e-03 | 2.45e-02 | 76 |
GO:000004511 | Prostate | Tumor | autophagosome assembly | 27/3246 | 99/18723 | 8.94e-03 | 3.87e-02 | 27 |
GO:009878012 | Prostate | Tumor | response to mitochondrial depolarisation | 8/3246 | 19/18723 | 1.00e-02 | 4.20e-02 | 8 |
GO:0019216 | Stomach | GC | regulation of lipid metabolic process | 37/1159 | 331/18723 | 3.67e-04 | 5.70e-03 | 37 |
GO:00224116 | Stomach | GC | cellular component disassembly | 42/1159 | 443/18723 | 3.99e-03 | 3.35e-02 | 42 |
GO:002241111 | Stomach | CSG | cellular component disassembly | 38/1034 | 443/18723 | 4.84e-03 | 4.04e-02 | 38 |
Page: 1 2 3 4 5 6 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0501018 | Cervix | CC | Alzheimer disease | 113/1267 | 384/8465 | 9.67e-14 | 3.92e-12 | 2.32e-12 | 113 |
hsa0501618 | Cervix | CC | Huntington disease | 94/1267 | 306/8465 | 8.49e-13 | 3.06e-11 | 1.81e-11 | 94 |
hsa0502218 | Cervix | CC | Pathways of neurodegeneration - multiple diseases | 128/1267 | 476/8465 | 2.87e-12 | 9.29e-11 | 5.50e-11 | 128 |
hsa0501418 | Cervix | CC | Amyotrophic lateral sclerosis | 103/1267 | 364/8465 | 1.79e-11 | 4.47e-10 | 2.64e-10 | 103 |
hsa0413718 | Cervix | CC | Mitophagy - animal | 22/1267 | 72/8465 | 5.77e-04 | 2.75e-03 | 1.63e-03 | 22 |
hsa0501716 | Cervix | CC | Spinocerebellar ataxia | 35/1267 | 143/8465 | 1.77e-03 | 7.21e-03 | 4.26e-03 | 35 |
hsa0501019 | Cervix | CC | Alzheimer disease | 113/1267 | 384/8465 | 9.67e-14 | 3.92e-12 | 2.32e-12 | 113 |
hsa0501619 | Cervix | CC | Huntington disease | 94/1267 | 306/8465 | 8.49e-13 | 3.06e-11 | 1.81e-11 | 94 |
hsa0502219 | Cervix | CC | Pathways of neurodegeneration - multiple diseases | 128/1267 | 476/8465 | 2.87e-12 | 9.29e-11 | 5.50e-11 | 128 |
hsa0501419 | Cervix | CC | Amyotrophic lateral sclerosis | 103/1267 | 364/8465 | 1.79e-11 | 4.47e-10 | 2.64e-10 | 103 |
hsa0413719 | Cervix | CC | Mitophagy - animal | 22/1267 | 72/8465 | 5.77e-04 | 2.75e-03 | 1.63e-03 | 22 |
hsa0501717 | Cervix | CC | Spinocerebellar ataxia | 35/1267 | 143/8465 | 1.77e-03 | 7.21e-03 | 4.26e-03 | 35 |
hsa05010 | Colorectum | AD | Alzheimer disease | 174/2092 | 384/8465 | 1.82e-19 | 9.26e-18 | 5.91e-18 | 174 |
hsa05014 | Colorectum | AD | Amyotrophic lateral sclerosis | 164/2092 | 364/8465 | 4.28e-18 | 1.27e-16 | 8.09e-17 | 164 |
hsa04140 | Colorectum | AD | Autophagy - animal | 49/2092 | 141/8465 | 4.58e-03 | 2.20e-02 | 1.40e-02 | 49 |
hsa050101 | Colorectum | AD | Alzheimer disease | 174/2092 | 384/8465 | 1.82e-19 | 9.26e-18 | 5.91e-18 | 174 |
hsa050141 | Colorectum | AD | Amyotrophic lateral sclerosis | 164/2092 | 364/8465 | 4.28e-18 | 1.27e-16 | 8.09e-17 | 164 |
hsa041401 | Colorectum | AD | Autophagy - animal | 49/2092 | 141/8465 | 4.58e-03 | 2.20e-02 | 1.40e-02 | 49 |
hsa050104 | Colorectum | MSS | Alzheimer disease | 169/1875 | 384/8465 | 1.21e-22 | 1.01e-20 | 6.21e-21 | 169 |
hsa050144 | Colorectum | MSS | Amyotrophic lateral sclerosis | 156/1875 | 364/8465 | 1.43e-19 | 4.62e-18 | 2.83e-18 | 156 |
Page: 1 2 3 4 5 6 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
AMBRA1 | SNV | Missense_Mutation | c.3511G>C | p.Ala1171Pro | p.A1171P | Q9C0C7 | protein_coding | deleterious_low_confidence(0.01) | benign(0.191) | TCGA-AN-A0FL-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
AMBRA1 | SNV | Missense_Mutation | c.3088N>T | p.Leu1030Phe | p.L1030F | Q9C0C7 | protein_coding | deleterious_low_confidence(0) | probably_damaging(0.997) | TCGA-AN-A0FW-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | |
AMBRA1 | SNV | Missense_Mutation | c.3428C>A | p.Thr1143Asn | p.T1143N | Q9C0C7 | protein_coding | tolerated_low_confidence(0.22) | benign(0.25) | TCGA-AR-A1AH-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unspecific | PD | ||
AMBRA1 | SNV | Missense_Mutation | novel | c.1648A>C | p.Thr550Pro | p.T550P | Q9C0C7 | protein_coding | tolerated_low_confidence(0.12) | benign(0.003) | TCGA-BH-A0WA-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
AMBRA1 | insertion | Nonsense_Mutation | novel | c.1877_1878insAGAGATAGGATAGG | p.Pro627GlufsTer4 | p.P627Efs*4 | Q9C0C7 | protein_coding | TCGA-A7-A0CJ-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cytoxan | SD | ||
AMBRA1 | insertion | In_Frame_Ins | novel | c.1876_1877insATCTTGCTCTGGTGG | p.Thr626delinsAsnLeuAlaLeuValAla | p.T626delinsNLALVA | Q9C0C7 | protein_coding | TCGA-A7-A0CJ-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cytoxan | SD | ||
AMBRA1 | deletion | Frame_Shift_Del | c.3585delN | p.Ile1196PhefsTer17 | p.I1196Ffs*17 | Q9C0C7 | protein_coding | TCGA-A8-A075-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | epirubicin | CR | |||
AMBRA1 | insertion | Nonsense_Mutation | novel | c.2822_2823insCTAAGCCTAGCCTGCTCAGGCTGCTCTTGGAGCTG | p.Met941IlefsTer2 | p.M941Ifs*2 | Q9C0C7 | protein_coding | TCGA-A8-A09D-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | CR | ||
AMBRA1 | insertion | Frame_Shift_Ins | novel | c.1861_1862insATATATGTAT | p.Arg621HisfsTer6 | p.R621Hfs*6 | Q9C0C7 | protein_coding | TCGA-A8-A09X-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | ||
AMBRA1 | insertion | Frame_Shift_Ins | novel | c.1860_1861insAAAAAAAAATA | p.Arg621LysfsTer18 | p.R621Kfs*18 | Q9C0C7 | protein_coding | TCGA-A8-A09X-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |